Article
Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis
1 Dec 2017
Abstract excerpt
Angiogenesis inhibitors are important for cancer therapy, but clinically approved anti-angiogenic agents have shown only modest efficacy and can compromise wound healing. This necessitates the development of novel anti-angiogenesis therapies. Here, we show significantly increased EGFL6 expression in tumor versus wound or normal endothelial cells. Using a series of in vitro and in vivo studies with orthotopic and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
